Sfoglia per Rivista DIABETES CARE
Glucose abnormalities in patients with hepatitis C virus infection: Epidemiology and pathogenesis - Response to Lecube et al.
2006-01-01 Vespasiani Gentilucci, U; Picardi, A; Pozzilli, P
Inverse Relationship Between Organ-Specific Autoantibodies and Systemic Immune Mediators in Type 1 Diabetes and Type 2 Diabetes: Action LADA 11
2016-01-01 Schloot, Nc; Pham, Mn; Hawa, Mi; Pozzilli, P; Scherbaum, Wa; Schott, M; Kolb, H; Hunter, S; Schernthaner, G; Thivolet, C; Seissler, J; Leslie, Rd; Action LADA, Group
Is Glucose Control Important for Prevention of Cardiovascular Disease in Diabetes?
2013-01-01 Mannucci, E; Dicembrini, I; Lauria, A; Pozzilli, P
Low-Dose Otelixizumab Anti-CD3 Monoclonal Antibody DEFEND-1 Study: Results of the Randomized Phase III Study in Recent-Onset Human Type 1 Diabetes
2014-01-01 Aronson, R; Gottlieb, Pa; Christiansen, Js; Donner, Tw; Bosi, E; Bode, Bw; Pozzilli, P
Meta-analysis of nicotinamide treatment in patients with recent-onset IDDM
1996-01-01 Pozzilli, P; Browne, Pd; Kolb, H
Metabolic Syndrome and Autoimmune Diabetes: Action LADA 3
2009-01-01 Hawa, Mi; Thivolet, C; Mauricio, D; Alemanno, I; Cipponeri, E; Collier, D; Hunter, S; Buzzetti, R; de Leiva, A; Pozzilli, P; Leslie, Rdg
Metformin-induced pancreatitis.
2006-01-01 Fimognari, F.; Corsonello, A.; Pastorell, R.; Antonelli Incalzi, R
No protective effect of calcitriol on beta-cell function in recent-onset type 1 diabetesThe IMDIAB XIII trial
2010-01-01 Bizzarri, C; Pitocco, D; Napoli, N; Di Stasio, E; Maggi, D; Manfrini, S; Suraci, C; Cavallo, Mg; Cappa, M; Ghirlanda, G; Pozzilli, P; IMDIAB Group:, M Altomare; Astorri, E; Barchetta, I; Benevento, D; G Beretta Anguissola, ; Bizzarri, C; Buzzetti, R; Capizzi, M; Cappa, M; R Cassone Faldetta, M; G Cavallo, M; Cipolloni, L; Cipponeri, E; Costantino, F; Crinò, A; E Di Stasio, ; Fioriti, E; Ghirlanda, G; Guglielmi, C; Lauria, A; Maggi, D; R Maurizi, A; Moretti, C; Morbiducci, L; Palermo, A; Patera, P; Pitocco, D; Portuesi, R; Scrocca, R; Spera, S; Strollo, R; Suraci, C; Tubili, C; Tuccinardi, D; Valente, L; Visalli, N
Obesity, Autoimmunity, and Double Diabetes in Youth
2011-01-01 Pozzilli, P; Caprio, S; Guglielmi, C; Buzzetti, R
on behalf of the Action LADA Group: Time to insulin initiation cannot be used in defining latent autoimmune diabetes in adults. (vol 31, pg 439, 2008)
2008-01-01 Brophy, S; Yderstraede, K; Mauricio, D; Hunter, S; Hawa, M; Pozzilli, P; Schernthaner, G; Schloot, N; Buzzetti, R; Davies, H; Leslie, D; Williams, R
Phenformin-induced lactic acidosis in an older diabetic patient: a recurrent drama (phenformin and lactic acidosis)
2006-01-01 FIMOGNARI F., L; Pastorelli, R; Incalzi, R. A.; ANTONELLI INCALZI, RAFFAELE FRANCO
RELATIONSHIP BETWEEN DAIRY PRODUCT CONSUMPTION AND INCIDENCE OF IDDM IN CHILDHOOD IN ITALY
1994-01-01 Fava, D; Leslie, Rdg; Pozzilli, P
The protein tyrosine phosphatase nonreceptor 22 (PTPN22) is associated with high GAD antibody titer in latent autoimmune diabetes in adults - Non Insulin Requiring Autoimmune Diabetes (NIRAD) study 3
2008-01-01 Petrone, A; Suraci, C; Capizzi, M; Giaccari, A; Bosi, E; Tiberti, C; Cossu, E; Pozzilli, P; Falorni, A; Buzzetti, R
Time to insulin initiation cannot be used in defining latent autoimmune diabetes in adults
2008-01-01 Brophy, S; Yderstrede, K; Mauricio, D; Hunter, S; Hawa, M; Pozzilli, P; Schernthaner, G; Schoot, N; Buzzetti, R; Davies, H; Leslie, D; Williams, R
Treatment of Recent- Onset Type 1 Diabetic Patients With DiaPep277: Results of a Double- Blind, PlaceboControlled, Randomized Phase 3 Trial
2014-01-01 Raz, I; Ziegler, Ag; Linn, T; Schernthaner, G; Bonnici, F; Distiller, La; Giordano, C; Giorgino, F; de Vries, L; Mauricio, D; Prochazka, V; Wainstein, J; Elias, D; Avron, A; Tamir, M; Eren, R; Peled, D; Dagan, S; Cohen, Ir; Pozzilli, P
Treatment of Recent-Onset Type 1 Diabetic Patients With DiaPep277: Results of a Double-Blind, Placebo-Controlled, Randomized Phase 3 Trial (vol 37, pg 1392, 2014)
2015-01-01 Raz, I; Ziegler, Ag; Linn, T; Schernthaner, G; Bonnici, F; Distiller, La; Giordano, C; Giorgino, F; de Vries, L; Mauricio, D; Prochazka, V; Wainstein, J; Elias, D; Avron, A; Tamir, M; Eren, R; Peled, D; Dagan, S; Cohen, Ir; Pozzilli, P
TYPE-I DIABETES MASQUERADING AS TYPE-II DIABETES - POSSIBLE IMPLICATIONS FOR PREVENTION AND TREATMENT
1994-01-01 Leslie, Rdg; Pozzilli, P
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Glucose abnormalities in patients with hepatitis C virus infection: Epidemiology and pathogenesis - Response to Lecube et al. | 1-gen-2006 | Vespasiani Gentilucci, U; Picardi, A; Pozzilli, P | |
Inverse Relationship Between Organ-Specific Autoantibodies and Systemic Immune Mediators in Type 1 Diabetes and Type 2 Diabetes: Action LADA 11 | 1-gen-2016 | Schloot, Nc; Pham, Mn; Hawa, Mi; Pozzilli, P; Scherbaum, Wa; Schott, M; Kolb, H; Hunter, S; Schernthaner, G; Thivolet, C; Seissler, J; Leslie, Rd; Action LADA, Group | |
Is Glucose Control Important for Prevention of Cardiovascular Disease in Diabetes? | 1-gen-2013 | Mannucci, E; Dicembrini, I; Lauria, A; Pozzilli, P | |
Low-Dose Otelixizumab Anti-CD3 Monoclonal Antibody DEFEND-1 Study: Results of the Randomized Phase III Study in Recent-Onset Human Type 1 Diabetes | 1-gen-2014 | Aronson, R; Gottlieb, Pa; Christiansen, Js; Donner, Tw; Bosi, E; Bode, Bw; Pozzilli, P | |
Meta-analysis of nicotinamide treatment in patients with recent-onset IDDM | 1-gen-1996 | Pozzilli, P; Browne, Pd; Kolb, H | |
Metabolic Syndrome and Autoimmune Diabetes: Action LADA 3 | 1-gen-2009 | Hawa, Mi; Thivolet, C; Mauricio, D; Alemanno, I; Cipponeri, E; Collier, D; Hunter, S; Buzzetti, R; de Leiva, A; Pozzilli, P; Leslie, Rdg | |
Metformin-induced pancreatitis. | 1-gen-2006 | Fimognari, F.; Corsonello, A.; Pastorell, R.; Antonelli Incalzi, R | |
No protective effect of calcitriol on beta-cell function in recent-onset type 1 diabetesThe IMDIAB XIII trial | 1-gen-2010 | Bizzarri, C; Pitocco, D; Napoli, N; Di Stasio, E; Maggi, D; Manfrini, S; Suraci, C; Cavallo, Mg; Cappa, M; Ghirlanda, G; Pozzilli, P; IMDIAB Group:, M Altomare; Astorri, E; Barchetta, I; Benevento, D; G Beretta Anguissola, ; Bizzarri, C; Buzzetti, R; Capizzi, M; Cappa, M; R Cassone Faldetta, M; G Cavallo, M; Cipolloni, L; Cipponeri, E; Costantino, F; Crinò, A; E Di Stasio, ; Fioriti, E; Ghirlanda, G; Guglielmi, C; Lauria, A; Maggi, D; R Maurizi, A; Moretti, C; Morbiducci, L; Palermo, A; Patera, P; Pitocco, D; Portuesi, R; Scrocca, R; Spera, S; Strollo, R; Suraci, C; Tubili, C; Tuccinardi, D; Valente, L; Visalli, N | |
Obesity, Autoimmunity, and Double Diabetes in Youth | 1-gen-2011 | Pozzilli, P; Caprio, S; Guglielmi, C; Buzzetti, R | |
on behalf of the Action LADA Group: Time to insulin initiation cannot be used in defining latent autoimmune diabetes in adults. (vol 31, pg 439, 2008) | 1-gen-2008 | Brophy, S; Yderstraede, K; Mauricio, D; Hunter, S; Hawa, M; Pozzilli, P; Schernthaner, G; Schloot, N; Buzzetti, R; Davies, H; Leslie, D; Williams, R | |
Phenformin-induced lactic acidosis in an older diabetic patient: a recurrent drama (phenformin and lactic acidosis) | 1-gen-2006 | FIMOGNARI F., L; Pastorelli, R; Incalzi, R. A.; ANTONELLI INCALZI, RAFFAELE FRANCO | |
RELATIONSHIP BETWEEN DAIRY PRODUCT CONSUMPTION AND INCIDENCE OF IDDM IN CHILDHOOD IN ITALY | 1-gen-1994 | Fava, D; Leslie, Rdg; Pozzilli, P | |
The protein tyrosine phosphatase nonreceptor 22 (PTPN22) is associated with high GAD antibody titer in latent autoimmune diabetes in adults - Non Insulin Requiring Autoimmune Diabetes (NIRAD) study 3 | 1-gen-2008 | Petrone, A; Suraci, C; Capizzi, M; Giaccari, A; Bosi, E; Tiberti, C; Cossu, E; Pozzilli, P; Falorni, A; Buzzetti, R | |
Time to insulin initiation cannot be used in defining latent autoimmune diabetes in adults | 1-gen-2008 | Brophy, S; Yderstrede, K; Mauricio, D; Hunter, S; Hawa, M; Pozzilli, P; Schernthaner, G; Schoot, N; Buzzetti, R; Davies, H; Leslie, D; Williams, R | |
Treatment of Recent- Onset Type 1 Diabetic Patients With DiaPep277: Results of a Double- Blind, PlaceboControlled, Randomized Phase 3 Trial | 1-gen-2014 | Raz, I; Ziegler, Ag; Linn, T; Schernthaner, G; Bonnici, F; Distiller, La; Giordano, C; Giorgino, F; de Vries, L; Mauricio, D; Prochazka, V; Wainstein, J; Elias, D; Avron, A; Tamir, M; Eren, R; Peled, D; Dagan, S; Cohen, Ir; Pozzilli, P | |
Treatment of Recent-Onset Type 1 Diabetic Patients With DiaPep277: Results of a Double-Blind, Placebo-Controlled, Randomized Phase 3 Trial (vol 37, pg 1392, 2014) | 1-gen-2015 | Raz, I; Ziegler, Ag; Linn, T; Schernthaner, G; Bonnici, F; Distiller, La; Giordano, C; Giorgino, F; de Vries, L; Mauricio, D; Prochazka, V; Wainstein, J; Elias, D; Avron, A; Tamir, M; Eren, R; Peled, D; Dagan, S; Cohen, Ir; Pozzilli, P | |
TYPE-I DIABETES MASQUERADING AS TYPE-II DIABETES - POSSIBLE IMPLICATIONS FOR PREVENTION AND TREATMENT | 1-gen-1994 | Leslie, Rdg; Pozzilli, P |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile